Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life

D. Snape, Matthew; Dawson, Tom; Oster, Philipp; E. J. Evans, A.; M. John, Tessa; Ohene-Kena, Brigitte; Findlow, Jamie; Yu, Ly‐Mee; Borrow, Ray; Ypma, Ellen; Toneatto, Daniela; J. Pollard, Andrew

doi:10.1097/inf.0b013e3181f59f6d

Public

Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life

Published in The Pediatric Infectious Disease Journal • Sep 15, 2010

Authors:

Matthew D. Snape

Tom Dawson

Philipp Oster

Abstract

BACKGROUND: An investigational vaccine against serogroup B meningococcal (MenB) disease containing 3 main recombinant proteins (factor H-binding protein, Neisserial adhesion A, and Neisserial heparin-binding antigen) has been developed. We evaluated the immunogenicity and reactogenicity of a 3-dose ...

Subject

Immunogenicity

Meningococcal vaccine

Virology

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!